[go: up one dir, main page]

ES8701228A1 - Un metodo para producir una propioxantina - Google Patents

Un metodo para producir una propioxantina

Info

Publication number
ES8701228A1
ES8701228A1 ES547630A ES547630A ES8701228A1 ES 8701228 A1 ES8701228 A1 ES 8701228A1 ES 547630 A ES547630 A ES 547630A ES 547630 A ES547630 A ES 547630A ES 8701228 A1 ES8701228 A1 ES 8701228A1
Authority
ES
Spain
Prior art keywords
enkephalinase
inhibitors
preparation
same
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES547630A
Other languages
English (en)
Other versions
ES547630A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of ES547630A0 publication Critical patent/ES547630A0/es
Publication of ES8701228A1 publication Critical patent/ES8701228A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE PROPIOXATINA, DE FORMULA (I), Y DE SUS SALES. COMPRENDE EL CULTIVO DE UN ORGANISMO PRODUCTOR DE PROPIOXATINA, DEL GENERO KITASATOSPORIA EN UN MEDIO DE CULTIVO AGITADO O SUMERGIDO, QUE CONTIENE FUENTES NUTRIENTES DE CARBONO Y DE NITROGENO Y SALES INORGANICAS, A UN PH ENTRE 5,5 Y 8,0 Y A UNA TEMPERATURA COMPRENDIDA ENTRE 6JC Y 38JC. SEPARACION DE LAS PROPIOXATINAS DEL MEDIO DE CULTIVO Y PURIFICACION DE LAS MISMAS SIGUIENDO TECNICAS CONVENCIONALES. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD COMO ANALGESICOS.
ES547630A 1984-10-04 1985-10-04 Un metodo para producir una propioxantina Expired ES8701228A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59208789A JPS6188884A (ja) 1984-10-04 1984-10-04 エンケフアリナ−ゼｂ阻害物質およびその製法

Publications (2)

Publication Number Publication Date
ES547630A0 ES547630A0 (es) 1986-11-16
ES8701228A1 true ES8701228A1 (es) 1986-11-16

Family

ID=16562134

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547630A Expired ES8701228A1 (es) 1984-10-04 1985-10-04 Un metodo para producir una propioxantina

Country Status (7)

Country Link
US (1) US4804676A (es)
EP (1) EP0177366B1 (es)
JP (1) JPS6188884A (es)
AT (1) ATE84045T1 (es)
CA (1) CA1277623C (es)
DE (1) DE3586935T2 (es)
ES (1) ES8701228A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2746372B2 (ja) * 1988-03-11 1998-05-06 科研製薬株式会社 Ｆ−０３６８物質
US7030114B1 (en) 1997-07-31 2006-04-18 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6492421B1 (en) 1997-07-31 2002-12-10 Athena Neurosciences, Inc. Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
US6583139B1 (en) * 1997-07-31 2003-06-24 Eugene D. Thorsett Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6423688B1 (en) 1997-07-31 2002-07-23 Athena Neurosciences, Inc. Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4
US6559127B1 (en) * 1997-07-31 2003-05-06 Athena Neurosciences, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6939855B2 (en) * 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
US6362341B1 (en) 1997-07-31 2002-03-26 Athena Neurosciences, Inc. Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4
US6797820B2 (en) 1999-12-17 2004-09-28 Vicuron Pharmaceuticals Inc. Succinate compounds, compositions and methods of use and preparation
JP2003534239A (ja) * 1999-12-17 2003-11-18 ヴァージコア・インコーポレーテッド 新規なスクシナート化合物、組成物、並びに使用及び調製方法
US20040006093A1 (en) * 2000-10-17 2004-01-08 Thorsett Eugene D. Compounds which inhibit leukocyte adhesion mediated by VLA-4
PT1406893E (pt) * 2001-06-15 2007-07-12 Vicuron Pharm Inc Compostos bicíclicos de pirrolidina
AR036053A1 (es) * 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
GB0509223D0 (en) 2005-05-05 2005-06-15 Chroma Therapeutics Ltd Enzyme inhibitors
MY200300A (en) 2016-04-21 2023-12-19 4TEEN4 Pharmaceuticals GmbH Methods for determining dpp3 and therapeutic methods
KR102835427B1 (ko) 2017-10-25 2025-07-21 4틴4 파마슈티컬스 게엠베하 특이적 dpp3-에피토프에 대하여 지시되고 이에 결합하는 dpp3 결합제 및 산화적 스트레스와 연관되는 질환 / 급성 병태의 예방 또는 치료에서의 그의 용도
EP3922993A1 (en) 2020-06-12 2021-12-15 4TEEN4 Pharmaceuticals GmbH Dpp3 in patients infected with coronavirus
WO2021185786A1 (en) 2020-03-16 2021-09-23 4TEEN4 Pharmaceuticals GmbH Dpp3 in patients infected with coronavirus
EP4633659A1 (en) 2022-12-15 2025-10-22 4TEEN4 Pharmaceuticals GmbH Dpp3 inhibitor for improvement of pulmonary function in critically ill patients
WO2024200862A1 (en) 2023-03-29 2024-10-03 4TEEN4 Pharmaceuticals GmbH Dpp3 inhibitor for myocardial protection and prevention of myocardial injury in critically ill patients with blood pressure decline
WO2025248139A1 (en) 2024-05-31 2025-12-04 4TEEN4 Pharmaceuticals GmbH Use of adrenomedullin or fragments thereof in the treatment of a patient in need thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284561A (en) * 1979-12-03 1981-08-18 E. R. Squibb & Sons, Inc. Hydroxamic acid derivatives of mercaptoacyl amino acids
JPS5697266A (en) * 1979-12-28 1981-08-05 Tanabe Seiyaku Co Ltd Proline derivative and its preparation
JPS56139455A (en) * 1980-04-02 1981-10-30 Santen Pharmaceut Co Ltd Sulfur-containing acylaminoacid
FR2518088B1 (fr) * 1981-12-16 1987-11-27 Roques Bernard Nouveaux derives d'aminoacides, et leur application therapeutique
JPS6115840A (ja) * 1984-07-03 1986-01-23 Microbial Chem Res Found 免疫賦活剤

Also Published As

Publication number Publication date
EP0177366A3 (en) 1988-08-10
ES547630A0 (es) 1986-11-16
CA1277623C (en) 1990-12-11
EP0177366A2 (en) 1986-04-09
JPH0413358B2 (es) 1992-03-09
ATE84045T1 (de) 1993-01-15
DE3586935D1 (de) 1993-02-11
JPS6188884A (ja) 1986-05-07
US4804676A (en) 1989-02-14
EP0177366B1 (en) 1992-12-30
DE3586935T2 (de) 1993-07-22

Similar Documents

Publication Publication Date Title
ES8701228A1 (es) Un metodo para producir una propioxantina
NO308792B1 (no) Derivater av valproinsyre og 2-valproensyreamider, farmasøytisk sammensetning derav og deres anvendelse for fremstilling av et farmasøytisk preparat
BG108806A (en) IIb/IIIa CELL ADHESION INHIIBITORS, METHOD FOR THE PRODUCTION, PHARMACEUTCIAL COMPOSITION AND ADMINISTRATION THEREOF
IL81002A (en) 3,4-diphenyl-pyrazoline-1-carboxamide derivatives,processes for the preparation thereof and insecticidal and acaricidal compositions containing the same
GB2071088B (en) Indane derivatives
MX9307509A (es) Metodo y preparacion farmaceutica para reducir la actividad de las celulas.
ES8702427A1 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
ES8207124A1 (es) Un procedimiento para la preparacion de derivados de aminas secundarias.
ES2109131A1 (es) Composicion farmaceutica que tiene actividad analgesica.
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT70531A (en) Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
EP1122252A4 (en) CONDENSED HEREROCYCLIC NITROGEN COMPOUNDS; MANUFACTURING PROCESS AND AGENTS CONTAINING THEM
IL63782A (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles,their preparation and pharmaceutical compositions containing them
ES8404852A1 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
EP0138616A3 (en) Nona- and dodecapeptides for augmenting natural killer cell activity, processes for making them and pharmaceutical compositions comprising them
DK0581904T3 (da) Fremgangsmåde til inhibering af fibrose
IL72668A0 (en) Benzoic acid derivatives,their preparation and pharmaceutical compositions containing them
ATE50248T1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
ES8609482A1 (es) Un metodo para producir acido dihidrodesoxigriseolico y sa- les y esteres del mismo
ES2000681A6 (es) Un procedimiento para preparar nuevos compuestos de bencilpiperazina
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
ZA84571B (en) Compounds derived from amides of mercaptoacetic acid and from 3-mercaptopropionic acid and pharmaceutical compositions containing them
ES8801633A1 (es) Procedimiento para preparar nuevos derivados de 3-piridil-metilnaftilo
AU581856B2 (en) 1-(4'-alkylthiophenyl)-2-amino-1, 3-propanediol N-substituted derivatives
ES8604121A1 (es) Procedimiento para la preparacion de esteres de acido guani-dinobenzoico

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519